Search Results

Maryland PDAB: How to Follow the Letter of the Law While Breaking Its Spirit Maryland's Prescription On March 18, 2025, the Maryland PDAB posted a revised agenda for their upcoming March 24 meeting. The Maryland PDAB's approach creates a veneer of public engagement while practically guaranteeing that The Maryland case isn't an anomaly. From Maryland's last-minute document dumps to Colorado's refusal to conduct impact analyses and Oregon's

enacting PDAB legislation: Washington, Oregon, Colorado, Michigan, Minnesota, New Jersey, New Hampshire, Maryland have the ability to enact binding upper payment limit (UPL) settings: Washington, Oregon, Colorado, Maryland

on the total number of drugs on each state's "Eligible for Review" list (or "Selected for Review" in Maryland's In Maryland and Oregon, every drug eligible for review falls into these categories. Maryland's PDAB focuses on endocrine disorders, autoimmune disorders, and respiratory disorders.

massive coalition of 60 entities, including a nurses’ union, and startling data supporting the need for Maryland While Maryland already had certain patient protections from these predatory practices on the books, too

the medicines at a discount to other co-conspirators running distribution companies in Mississippi, Maryland

In Maryland, carriers requested 17.1% increases, but rates would drop to 7.9% if Congress extends enhanced

massive overcharges: Ohio lost $224.8 million in one year, Pennsylvania $605 million over four years, and Maryland

Colorado and Maryland, the two states furthest along in setting Upper Payment Limits (UPLs), are basing

Medicaid Formulary Ohio – Ohio has a Unified Medicaid Formulary that applies to all MCOs Georgia and Maryland

Maryland has removed Epclusa (brand) from its Medicaid PDL.

Maryland changed Harvoni from preferred to non-preferred status requiring prior authorization, while

Maryland changed Harvoni from preferred to non-preferred status requiring prior authorization, while